Clinical trial · Interventional
Pain in Oncolgy: Evaluation of a Non Invasive Monitoring Device (ANI). A Monocentric Prospective Study
NCT02902627CI-TRIAL-00031751ANIONCOcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
l'ANI (Analgesia Nociception Index The main objective of the research is to estimate the Analgesia Nociception Index (ANI) as a parameter giving the possibility of measuring the pain in painful metastatic cancer. The parameter ANI is compared with visual analogical scale (VAS) score.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non Invasive Monitoring Device (ANI) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Metastatic cancer
- interventionNames
- Device: Non Invasive Monitoring Device (ANI)
Primary outcomes (1)
- measure
- Comparison of the ANI parameter with the VAS
- timeFrame
- 4 hours
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * more than 18 years, -no legal protection, - * life expectancy is considered over 3-months * not receiving of béta-blocking, * Having a rhythm sinusal without extrasystole * benefiting from a coverage by a social security system Exclusion Criteria: * Pace-Maker * Diabetes mellitus
References
Publications (0)
Data not yet available
No reference posted for this study.